Matches in Wikidata for { <http://www.wikidata.org/entity/Q65381214> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q65381214 description "clinical trial" @default.
- Q65381214 description "ensayu clínicu" @default.
- Q65381214 description "klinisch onderzoek" @default.
- Q65381214 description "клінічне випробування" @default.
- Q65381214 name "Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma" @default.
- Q65381214 name "Safety of Indacaterol in Patients" @default.
- Q65381214 type Item @default.
- Q65381214 label "Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma" @default.
- Q65381214 label "Safety of Indacaterol in Patients" @default.
- Q65381214 prefLabel "Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma" @default.
- Q65381214 prefLabel "Safety of Indacaterol in Patients" @default.
- Q65381214 P1050 Q65381214-729D2D86-E8EC-49BD-ADA2-CF3772598F43 @default.
- Q65381214 P1132 Q65381214-9CC5D849-7CA8-40D8-9EB0-8E10BABC16AC @default.
- Q65381214 P1476 Q65381214-4AB726AB-634F-4E09-A559-44034124D980 @default.
- Q65381214 P17 Q65381214-04B780A7-FA67-4CB4-9F3C-66FE92BF8E69 @default.
- Q65381214 P17 Q65381214-2EF5510B-2996-4EDE-B8B2-F31104911837 @default.
- Q65381214 P17 Q65381214-38171969-C52D-49A1-A6D4-87F7D344941C @default.
- Q65381214 P17 Q65381214-3D8EB298-7111-4C84-91F9-0183261E5A36 @default.
- Q65381214 P17 Q65381214-9AB64439-0975-490C-B309-8E57E36E95E8 @default.
- Q65381214 P17 Q65381214-9DC9E47E-D5A9-42FE-931E-0F4760845020 @default.
- Q65381214 P17 Q65381214-9F539347-955C-49F2-B116-1D8EB20FEF14 @default.
- Q65381214 P17 Q65381214-D1A263B7-403C-46D9-936D-1FA0CF33DAA1 @default.
- Q65381214 P17 Q65381214-D5A6CDEF-C152-4B90-882A-BB8DC4B341FA @default.
- Q65381214 P17 Q65381214-F9008BA4-B065-4C99-A6A9-428B41B2B407 @default.
- Q65381214 P17 Q65381214-FB7BBCAA-B293-4ED6-BFF1-6C9B7413DBA4 @default.
- Q65381214 P17 Q65381214-FD1AAD7C-C433-4ACC-A557-91C27BDB1692 @default.
- Q65381214 P2899 Q65381214-FBF4A2F2-03C0-4926-AE70-106C83895951 @default.
- Q65381214 P3098 Q65381214-9EDD5669-D58D-431E-894B-1FB9F76844E8 @default.
- Q65381214 P31 Q65381214-06AF56A0-1FF4-4136-A44D-C80961868D90 @default.
- Q65381214 P4844 Q65381214-7E9E118F-E636-4A1F-8EF0-D8049A427C47 @default.
- Q65381214 P580 Q65381214-B3EA7737-58B2-43D0-952E-75B81D2F8238 @default.
- Q65381214 P582 Q65381214-EA3DB4DB-1712-4AA7-883D-1FA89737BDDD @default.
- Q65381214 P6099 Q65381214-653B9941-26C6-4148-B6B8-920B611C7F0F @default.
- Q65381214 P6153 Q65381214-F6B7434E-0F3A-4135-A51C-2FDF806F7BE7 @default.
- Q65381214 P8363 Q65381214-1561F3D3-A1CD-4BDA-9647-0425243C4563 @default.
- Q65381214 P859 Q65381214-7E1D470B-F951-4E35-8CB3-E68A182D03D6 @default.
- Q65381214 P1050 Q35869 @default.
- Q65381214 P1132 "+805" @default.
- Q65381214 P1476 "A 26-week Treatment, Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study to Assess the Safety of Indacaterol (300 and 600 µg o.d.) in Patients With Moderate to Severe Persistent Asthma, Using Salmeterol (50 µg b.i.d.) as an Active Control" @default.
- Q65381214 P17 Q142 @default.
- Q65381214 P17 Q16 @default.
- Q65381214 P17 Q183 @default.
- Q65381214 P17 Q213 @default.
- Q65381214 P17 Q214 @default.
- Q65381214 P17 Q28 @default.
- Q65381214 P17 Q29 @default.
- Q65381214 P17 Q30 @default.
- Q65381214 P17 Q38 @default.
- Q65381214 P17 Q414 @default.
- Q65381214 P17 Q419 @default.
- Q65381214 P17 Q43 @default.
- Q65381214 P2899 "+12" @default.
- Q65381214 P3098 "NCT00529529" @default.
- Q65381214 P31 Q30612 @default.
- Q65381214 P4844 Q27264747 @default.
- Q65381214 P580 "2007-09-01T00:00:00Z" @default.
- Q65381214 P582 "2008-08-01T00:00:00Z" @default.
- Q65381214 P6099 Q42824827 @default.
- Q65381214 P6153 Q507154 @default.
- Q65381214 P8363 Q78089383 @default.
- Q65381214 P859 Q507154 @default.